Navin Fluorine
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Navin Fluorine International Ltd (NFIL) is strategically pivoting towards high-value, technology-driven segments, particularly in Advanced Materials and Contract Development and Manufacturing Organization (CDMO), which are expected to drive significant revenue growth. Management's commitment to a substantial capital expenditure program of INR 7,000-10,000 million annually through FY30 underscores their confidence in achieving a 20-25% CAGR in top-line growth, supported by strong order visibility and long-term contracts. The company's focus on optimizing existing capacities while expanding into new markets positions it favorably against competitors, particularly as it serves as an alternative to Chinese supply chains. However, execution risks related to the ambitious capex plans and potential pricing pressures in the agrochemical sector remain critical watchpoints. Vista's financial outlook reflects a stable revenue trajectory with improving margins, supported by the company's net-debt-free status and attractive valuation relative to intrinsic value estimates. The macroeconomic environment remains mixed, with inflationary pressures and currency fluctuations posing challenges. Over the next 12-24 months, NFIL's growth will hinge on successful execution of its strategic initiatives and the ability to navigate market dynamics effectively
Why We Like This Stock
- Strategic pivot towards high-margin Advanced Materials and CDMO segments expected to drive significant revenue growth
- Strong order visibility and long-term contracts support management's target of 20-25% CAGR in top-line growth
- Net-debt-free status and attractive valuation relative to intrinsic value estimates enhance financial stability
Things To Watch Out For
- Execution risks associated with ambitious capital expenditure plans could impact growth timelines
- Pricing pressures in the agrochemical sector may affect margins and overall profitability
- Inflationary pressures and currency fluctuations present ongoing challenges in the macroeconomic environment
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 2,065 | 2,349 | 3,314 | 3,822 | 4,471 |
| Profit Before Tax (Cr.) | 285 | 380 | 880 | 1,105 | 1,274 |
| PBT Margin | 13.8% | 16.2% | 26.6% | 28.9% | 28.5% |
| Net Profit (Cr.) | 236 | 300 | 669 | 840 | 968 |
| Earnings Per Share | 46.0 | 58.4 | 130.4 | 163.7 | 188.7 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Axis Securities | ▲ Buy | 9,040 | 21-Aug-2026 |
| Kotak Securities | ▼ Sell | 5,250 | 21-Aug-2026 |
| Prabhudas Liladhar | ► Accumulate | 8,812 | 21-Aug-2026 |
| Citigroup | ▼ Sell | 7,200 | 06-Aug-2026 |
| Deven Choksey | ▼ Reduce | 8,443 | 06-Aug-2026 |
| Jeffries | ▲ Buy | 9,045 | 06-Aug-2026 |
| Motilal Oswal | ► Neutral | 8,300 | 06-Aug-2026 |
| UBS | ► Accumulate | 8,377 | 06-Aug-2026 |
| Geojit Financials | ▲ Buy | 8,500 | 06-May-2026 |
| Moneycontrol | ▲ Overweight | nan | 05-May-2026 |
| DAM Capital | ▲ Buy | 7,769 | 30-Apr-2026 |
| Elara Capital | ▲ Buy | 8,681 | 30-Apr-2026 |
| IDBI Capital | ▲ Buy | 8,265 | 30-Apr-2026 |
Company Overview
Show Company Profile
Navin Fluorine International Limited manufactures and sells specialty fluorochemicals in India and internationally. The company offers refrigerants for various applications, including room air conditioning, commercial refrigeration, industrial cooling, mobile air conditioning, cold chain, and heat pumps under the Mafron brand for original equipment manufacturers, service technicians, and equipment owners. It also provides inorganic fluoride products, such as hydrogen fluoride, diluted hydrofluoric acid, ammonium bifluoride, potassium fluoride, sodium fluoride, hexafluorophosphoric acid, hydrogen fluoridepyridine complex, and fluoboric acid for oil and gas, steel and abrasives, industrial glass and specialty performance materials, pharmaceutical and agrochemicals, and medical surface treatment applications; and specialty fluorochemicals comprising benzotrifluoride, 2-chloro-5-(trifluoromethyl)pyridine, 4-fluorophenol, 3-aminobenzotrifluoride, 4-fluorobenzonitrile, 4-fluorobenzoic acid, and 3-chlorobenzotrifluoride. The company was founded in 1967 and is based in Mumbai, India.